echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nat Commun Wang Yiguang's team provides a new strategy for analyzing the intracellular and intracellular distribution of nanomedicine and its contribution to efficacy

    Nat Commun Wang Yiguang's team provides a new strategy for analyzing the intracellular and intracellular distribution of nanomedicine and its contribution to efficacy

    • Last Update: 2022-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 14, 2022, the internationally renowned journal Nature Communications published online the latest research results of Wang Yiguang's research team from the State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmacy, Peking University, "Dissecting extracellular and intracellular distribution of nanoparticles and their contribution to therapeutic response by "monochromatic ratiometric imaging" ( monochromatic ratiometric imaging technology to analyze the intracellular and extracellular distribution of nanomedicine and its contribution to the therapeutic effect)


    In recent years, nanomedicines have received extensive attention in cancer treatment


    Wang Yiguang's research team developed a pH/light dual-responsive monochromatic ratio imaging nanoparticle (MRIN) based on the group's existing pH-sensitive (Ultra-pH-sensitive, UPS) nanotechnology platform.


    Using this technology, Wang Yiguang's research team successfully analyzed the contribution of extracellular nanophotosensitizers to tumor treatment


    Researcher Wang Yiguang of Peking University School of Pharmacy is the corresponding author of this research paper


    Paper link: https://

    【Profile of Researcher Wang Yiguang】

    Wang Yiguang, researcher and doctoral supervisor of Peking University, director of the Department of Pharmacy, School of Pharmacy, PI of the State Key Laboratory of Natural and Biomimetic Drugs



    (School of Pharmacy, Peking University)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.